| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| The Ramaraju Surgical Cotton Mills Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-Current Assets |
|
|
|
Property, Plant & Equipments |
24,803.55 |
27,857.39 |
|
Capital Work-in-Progress |
50.77 |
230.81 |
|
Investment Property |
5.06 |
5.24 |
|
Goodwill |
1,951.50 |
1,951.50 |
|
Intengible assets |
413.51 |
471.97 |
|
Investments in Subsidiary and Associates |
17,306.26 |
19,338.10 |
|
Other Investments |
580.07 |
578.48 |
|
Other Financial Assets |
458.71 |
433.33 |
|
Deferred Tax assets |
2,147.11 |
1116.01 |
|
Other Non-current assets |
65.46 |
38.24 |
|
Current Assets |
|
|
|
Inventories |
13,172.64 |
11,560.21 |
|
Trade Receivables |
8,603.93 |
4,638.23 |
|
Cash And Cash Equivalents |
110.57 |
4,065.74 |
|
Bank balance other than cash and cash equivalents |
6.43 |
5.64 |
|
Other Financial Assets |
569.84 |
341.93 |
|
Current tax assets |
123.94 |
119.28 |
|
Other Current assets |
2,106.19 |
2,538.32 |
|
Total Assets |
72,475.54 |
75,290.42 |
|
Equity |
|
|
|
Equity Share Cpital |
581.5 |
581.5 |
|
Other Equity |
22,733.25 |
25,599.25 |
|
Non-Controlling Interest |
258.34 |
398.53 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
22,185.43 |
23,482.29 |
|
Provisions |
108.42 |
102.49 |
|
Deferred Tax Liabilities (Net) |
18.15 |
9.85 |
|
Other non-current Liabilities |
70.16 |
72.2 |
|
Current Liabilities |
|
|
|
Borrowings |
21,256.66 |
21,561.85 |
|
Total Outstanding dues of micro and small enterprises |
193.78 |
66.47 |
|
Total outstanding dues of creditors other than above |
3,048.94 |
1,196.27 |
|
Other Financial Liabilities |
1,213.86 |
1172.99 |
|
Other Current Liabilities |
380.41 |
655.91 |
|
Provisions |
426.64 |
390.82 |
|
Total Equity and Liabilities |
72,475.54 |
75,290.42 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Revenue from Operations |
|
|
|
Sale of Product |
39,397.11 |
36,064.62 |
|
Other Operating Income |
711.59 |
494.58 |
|
Other Income |
503.38 |
579.18 |
|
Total Income |
40,612.08 |
37,138.38 |
|
Expenses |
|
|
|
Cost of material consumed |
22,053.88 |
20,320.77 |
|
Purchase of stock-in-trade |
4,752.46 |
1,700.77 |
|
Changes in Inventories of Finished goods and Work-in-Progress Stock |
(1,560.48) |
(201.94) |
|
Employee Benefit Expenses |
6,292.99 |
5,594.48 |
|
Power and Fuel |
2,621.18 |
2,747.15 |
|
Finance Cost |
3,858.48 |
3,756.54 |
|
Depreciation and Amortisation Expenses |
2,948.34 |
3,543.14 |
|
Other Expenses |
5,687.39 |
4,703.98 |
|
Total Expenses |
46,654.24 |
42,164.89 |
|
Profit /(Loss) before Exceptional Items and Tax |
(6,042.16) |
(5,026.51) |
|
Exceptional Items |
1,689.70 |
- |
|
Profit Before Tax |
(4,352.46) |
(5,026.51) |
|
Tax Expenses earlier year |
- |
(82.50) |
|
Deferred Tax |
(1,568.40) |
(1,033.86) |
|
Mat Credit (taken)/withdrawn related to earlier year |
545.61 |
414.89 |
|
Profit/(Loss) from Ordinary activities After Tax |
(3,329.67) |
(4,325.04) |
|
Share of Net Profit after tax of of associates accounted for using the equity method |
408.28 |
550.62 |
|
Net Profit for the Period |
(2,921.39) |
(3,774.42) |
|
Shareholders of the Company |
(2,929.58) |
(3,771.14) |
|
Non Controlling Interest |
8.19 |
-3.28 |
|
Other Comprehensive Income/(Loss), net of tax |
-12.22 |
-26.96 |
|
Share of OCI of Associates accounted for using Equity Method |
-15.08 |
100.84 |
|
OCI - Foreign Currency Translation |
82.68 |
-8.68 |
|
Total Comphrensive Income after Tax |
-2,866.01 |
-3,709.22 |
|
Shareholders of the Company |
-2,874.20 |
-3,705.94 |
|
Non Controlling Interest |
8.19 |
-3.28 |
|
Paid Up Equity Share Capital |
581.50 |
581.50 |
|
Other Equity |
22,991.59 |
25,997.78 |
|
Earnings per Equity Share |
|
|
|
Basic |
-50.24 |
-93.86 |
|
Diluted |
-50.24 |
-93.86 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash flows from Operating Activities |
|
|
|
Profit before Tax and exceptional items |
(6,042.16) |
(5,026.51) |
|
Adjustments to reconcile profit/(loss): |
|
|
|
Depreciation & Amortisation |
2,948.34 |
3,543.14 |
|
Finance Cost |
3,858.48 |
3,756.54 |
|
Interest Received |
(272.90) |
(238.62) |
|
(Profit) / Loss on Sale of Assets |
63.44 |
(66.04) |
|
Government Grants |
(1.45) |
(1.45) |
|
Operating Profit before Working capital Changes |
553.75 |
1967.06 |
|
Movement in Working Capital: |
|
|
|
Trade Receivables |
(3965.70) |
(826.79) |
|
Inventories |
-1,612.43 |
1,413.11 |
|
Loans and Advances |
236.97 |
2.07 |
|
Trade Payables & Current Liabilities |
1861.90 |
(0.37) |
|
Cash Generated from Operating Activities |
-2925.51 |
2555.08 |
|
Direct Taxes refund received/(Paid) (Net) |
31.62 |
125.38 |
|
Net Cash Generated from Operating Activities |
-2,893.89 |
2680.46 |
|
Cash flows from Investing Activities |
|
|
|
Purchase of Fixed Assets |
(148.81) |
(1,743.52) |
|
Investment in Shares |
- |
(422.43) |
|
Proceeds from Sale of investment in associates |
4029.88 |
- |
|
Proceeds from Sale of assets |
402.34 |
495.85 |
|
Interest Received |
235.73 |
238.62 |
|
Net Cash Generated from Investing Activities |
4,519.14 |
(1,431.48) |
|
Cash Flows from Financing Activities |
|
|
|
Proceeds from right issue , Net of issue expenses |
- |
3655.17 |
|
Proceeds from Long Term Borrowings |
5,600.00 |
6,367.11 |
|
Repayment of Long Term Loan |
(6,896.86) |
(5,121.34) |
|
Proceeds / (Repayment) of Deposits - Related Parties |
903.62 |
- |
|
Proceeds / (Repayment) of Short Term Borrowings (Net) |
(1,208.81) |
1,524.83 |
|
Acquisition Non-Controlling Interest |
(140.19) |
-137.43 |
|
Payment Dividend |
- |
(19.99) |
|
Finance Cost |
(3,837.39) |
(3,756.54) |
|
Net Cash Generated from Financing Activities |
(5,579.63) |
2,511.81 |
|
Net Increase in Cash and Cash Equivalent |
(3,954.38) |
3,760.79 |
|
Opening balance of Cash and Cash Equivalents |
4,071.38 |
310.59 |
|
Closing balance of Cash and Cash Equivalents |
117.00 |
4,071.38 |
|
Cash and Cash Equivalents comprise the following: |
|
|
|
Cash and Cash Equivalents |
110.57 |
4065.74 |
|
Bank Balance Other Than Cash and Cash Equivalents |
6.43 |
5.64 |
|
Total |
117.00 |
4,071.38 |
Here is a summary of the Cash Flow Statement
for the years 2024 and 2025:
Operating
Activities:
In FY 2025, the
company reported a loss before tax and exceptional items of ₹6,042.16 lakhs, a
deeper loss compared to ₹5,026.51 lakhs in FY 2024. After accounting for
non-cash adjustments such as depreciation and amortisation (₹2,948.34 lakhs)
and finance costs (₹3,858.48 lakhs), the operating profit before working
capital changes was ₹553.75 lakhs, down from ₹1,967.06 lakhs in FY 2024.
However, significant cash outflows in working capital—particularly from trade
receivables (₹3,965.70 lakhs) and inventories (₹1,612.43 lakhs)—led to negative
cash generated from operations at ₹2,925.51 lakhs. After considering taxes, the
net
cash used in operating activities stood at ₹2,893.89
lakhs, in stark contrast to the positive
₹2,680.46 lakhs in the previous year.
Investing Activities:
In FY 2025, the
company showed a strong inflow from investing activities amounting to ₹4,519.14
lakhs, primarily driven by the ₹4,029.88 lakhs
from the sale of investments in associates and ₹402.34
lakhs from asset sales. This is a significant turnaround from
FY 2024, where investing activities saw a net outflow of ₹1,431.48
lakhs due to heavy purchases of fixed assets and investments in
shares.
Financing Activities:
The financing cash
flows in FY 2025 turned negative at ₹5,579.63 lakhs, mainly
due to the repayment
of long-term loans (₹6,896.86 lakhs) and high
finance costs (₹3,837.39 lakhs). This contrasts with the
previous year’s positive inflow of ₹2,511.81 lakhs,
which had included proceeds from a right issue and higher borrowings.
Net Cash Flow and Final Balances:
The overall result
was a net
decrease in cash and cash equivalents of ₹3,954.38 lakhs in FY
2025, following a strong increase of ₹3,760.79 lakhs in FY
2024. Consequently, the closing cash balance
as of 31st March 2025 dropped sharply to ₹117 lakhs, down from
₹4,071.38
lakhs the previous year.
Ramaraju Surgical Cotton Mills Limited Financial Ratios
|
2025 |
2024 |
|
|
Current Ratio |
1.20 |
1.19 |
|
Debt-Equity Ratio |
4.01 |
4.65 |
|
Debt Service
Coverage Ratio |
0.32 |
0.41 |
|
Return on Equity
(in %) |
6.45 |
(42) |
|
Inventory Turnover
Ratio (in days) |
101 |
120 |
|
Trade Receivables
Turnover Ratio (in days) |
64 |
52 |
|
Trade Payables
Turnover Ratio (in days) |
15 |
16 |
|
Net Capital
Turnover Ratio (in days) |
150 |
156 |
|
Net Profit Ratio
(in %) |
1.54 |
(10) |
|
Return on Capital
Employed (in %) |
8.86 |
(0.02) |
|
Return on
Investment (in %) |
1.08 |
(6.60) |
Here is a summary of the Financial Ratios for the years 2025 and 2024:
Current
Ratio
The
current ratio remained almost the same, at 1.19 in 2024 and 1.20 in 2025. This
means the company has just enough current assets to cover its short-term liabilities,
showing stable liquidity.
Debt-Equity Ratio
The
debt-equity ratio improved from 4.65 to 4.01. This shows a slight reduction in
reliance on debt, but the ratio is still high, meaning the company is heavily
dependent on borrowed funds.
Debt Service Coverage Ratio
This
ratio decreased from 0.41 to 0.32, showing a weaker ability to cover debt
repayments from earnings. A value below 1 indicates the company may struggle to
meet debt obligations.
Return on Equity (ROE)
ROE
improved from a loss of –42% in 2024 to a positive 6.45% in 2025. This is a
major turnaround, showing the company has moved from losses to generating a
profit for shareholders.
Inventory Turnover Ratio (in days)
The
inventory holding period reduced from 120 days to 101 days, meaning the company
is selling its stock faster, which is a positive sign for efficiency.
Trade Receivables Turnover Ratio (in days)
The
collection period increased from 52 days to 64 days, showing that customers are
taking longer to pay, which could impact cash flow.
Trade Payables Turnover Ratio (in days)
The
payment period slightly decreased from 16 days to 15 days, meaning the company
is paying suppliers a bit faster.
Net Capital Turnover Ratio (in days)
This
ratio improved slightly from 156 days to 150 days, meaning the company is using
its capital a bit more efficiently to generate sales.
Net Profit Ratio
The net
profit ratio improved significantly from –10% in 2024 to 1.54% in 2025, showing
the company has moved from losses to making a small profit.
Return on Capital Employed (ROCE)
ROCE
increased from –0.02% to 8.86%, showing a strong improvement in using capital
to generate profits.
Return on Investment (ROI)
ROI
improved from –6.60% to 1.08%, showing that investments are now generating positive
returns after a loss in the previous year.
